Literature DB >> 33383617

Balance between Retroviral Latency and Transcription: Based on HIV Model.

Aneta Pluta1, Juan P Jaworski2, César N Cortés-Rubio3.   

Abstract

The representative of the Lentivirus genus is the human immunodeficiency virus type 1 (HIV-1), the causative agent of acquired immunodeficiency syndrome (AIDS). To date, there is no cure for AIDS because of the existence of the HIV-1 reservoir. HIV-1 infection can persist for decades despite effective antiretroviral therapy (ART), due to the persistence of infectious latent viruses in long-lived resting memory CD4+ T cells, macrophages, monocytes, microglial cells, and other cell types. However, the biology of HIV-1 latency remains incompletely understood. Retroviral long terminal repeat region (LTR) plays an indispensable role in controlling viral gene expression. Regulation of the transcription initiation plays a crucial role in establishing and maintaining a retrovirus latency. Whether and how retroviruses establish latency and reactivate remains unclear. In this article, we describe what is known about the regulation of LTR-driven transcription in HIV-1, that is, the cis-elements present in the LTR, the role of LTR transcription factor binding sites in LTR-driven transcription, the role of HIV-1-encoded transactivator protein, hormonal effects on virus transcription, impact of LTR variability on transcription, and epigenetic control of retrovirus LTR. Finally, we focus on a novel clustered regularly interspaced short palindromic repeats-associated protein 9 (CRISPR/dCas9)-based strategy for HIV-1 reservoir purging.

Entities:  

Keywords:  HIV-1; LTR; human immunodeficiency virus type 1; latency and CRISPR/dCas9; regulation transcription; retroviruses; terminal repeat region

Year:  2020        PMID: 33383617      PMCID: PMC7824405          DOI: 10.3390/pathogens10010016

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  188 in total

1.  Chromatin disruption and histone acetylation in regulation of the human immunodeficiency virus type 1 long terminal repeat by thyroid hormone receptor.

Authors:  Shao-Chung Victor Hsia; Yun-Bo Shi
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

2.  HIV vaccine design and the neutralizing antibody problem.

Authors:  Dennis R Burton; Ronald C Desrosiers; Robert W Doms; Wayne C Koff; Peter D Kwong; John P Moore; Gary J Nabel; Joseph Sodroski; Ian A Wilson; Richard T Wyatt
Journal:  Nat Immunol       Date:  2004-03       Impact factor: 25.606

3.  The distribution of feline immunodeficiency virus in tissue compartments of feral domestic cats.

Authors:  Jessica J Hayward; Allen G Rodrigo
Journal:  Arch Virol       Date:  2010-01-29       Impact factor: 2.574

4.  The epigenetic magic of histone lysine methylation.

Authors:  Thomas Jenuwein
Journal:  FEBS J       Date:  2006-07       Impact factor: 5.542

5.  A nuclear protein with enhanced binding to methylated Sp1 sites in the AIDS virus promoter.

Authors:  P Joel; W Shao; K Pratt
Journal:  Nucleic Acids Res       Date:  1993-12-11       Impact factor: 16.971

6.  Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein.

Authors:  M O Hottiger; G J Nabel
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

7.  Induction of human immunodeficiency virus type 1 replication in human glial cells after proinflammatory cytokines stimulation: effect of IFNgamma, IL1beta, and TNFalpha on differentiation and chemokine production in glial cells.

Authors:  N Janabi; M Di Stefano; C Wallon; C Hery; F Chiodi; M Tardieu
Journal:  Glia       Date:  1998-08       Impact factor: 7.452

8.  Inactivation of the HIV LTR by DNA CpG methylation: evidence for a role in latency.

Authors:  D P Bednarik; J A Cook; P M Pitha
Journal:  EMBO J       Date:  1990-04       Impact factor: 11.598

9.  Latency profiles of full length HIV-1 molecular clone variants with a subtype specific promoter.

Authors:  Renée M van der Sluis; Georgios Pollakis; Marja L van Gerven; Ben Berkhout; Rienk E Jeeninga
Journal:  Retrovirology       Date:  2011-09-16       Impact factor: 4.602

10.  Functional Studies of CCAAT/Enhancer Binding Protein Site Located Downstream of the Transcriptional Start Site.

Authors:  Yujie Liu; Michael R Nonnemacher; Aikaterini Alexaki; Vanessa Pirrone; Anupam Banerjee; Luna Li; Evelyn Kilareski; Brian Wigdahl
Journal:  Clin Med Insights Pathol       Date:  2017-11-15
View more
  1 in total

1.  Molecular Biology and Diversification of Human Retroviruses.

Authors:  Morgan E Meissner; Nathaniel Talledge; Louis M Mansky
Journal:  Front Virol       Date:  2022-06-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.